- Healthcare stock Imricor Medical Systems (IMR) is on track to raise $30 million in additional equity via a placement and security purchase plan (SPP)
- Imricor first announced plans to raise capital last week, when it entered a trading halt
- The medical company has since announced it has successfully raised $28.45 million via a placement
- It’s also planning to raise an additional $1.55 million via an SPP, with those eligible invited to buy $30,000 worth of CHESS Depositary Interests (CDI)
- The CDIs represent new fully paid shares of Class A common stock in IMR and are on offer for $2.35 – the same price as the placement
- Shares in Imricor have ended the week up 5.18 percent worth $2.64 each
